Subjective: This study aimed to investigate the therapeutic mechanisms of 7-hydroxyflavone (7-HF) in treating myocardial ischemia/reperfusion injury (MI/RI) via network pharmacology, molecular docking, target validati...Subjective: This study aimed to investigate the therapeutic mechanisms of 7-hydroxyflavone (7-HF) in treating myocardial ischemia/reperfusion injury (MI/RI) via network pharmacology, molecular docking, target validation, and experiments at the animal level. Methods: Firstly, the genes of 7-HF were acquired from PharmMapper, TCMSP, and SwissTargetPrediction. At the same time, MI/RI-related genes were obtained from OMIM, GeneCards, and TTD online platforms. Subsequently, string platform and Cytoscape 3.9.2 were used to construct protein-protein interaction network diagrams and 7-HF-targets-signaling pathways-MI/RI network. Then, the Metascape platform was used to conduct functional enrichment analyses. Next, AutoDock Vina and Pymol were used to perform molecular docking. The hub targets were validated in the GSE66360. Lastly, SOD, MDA, transmission electron microscope, quantitative real-time PCR, and western blot were used to validate in MI/RI rats. Results: 139 genes of 7-HF, 4832 genes of MI/RI were obtained. The 47 interact genes between 7-HF and MI/RI targets for MI/RI were likely to act through multiple pathways. And NQO1 was a critical target in the above process. In an animal experiment, 7-HF could relieve the injured interfibrillar mitochondria and myocardial fibers, decrease the expression of MDA and SOD, and increase the expression of Nrf2, NQO1 and HO-1 in the mRNA and protein level in the MI/RI rats. Conclusion: This study preliminarily demonstrated that 7-HF could provide cardioprotection by inhibiting the oxidative stress and up-regulating Nrf2/NQO1/HO-1 signaling pathway based on network pharmacology, molecular docking, target validation, and animal experiments.展开更多
目的:探讨血管紧张素(1-7)[Ang(1-7)]对大鼠尿毒症高转性骨病的影响,并阐明其可能的机制。方法:30只SD大鼠随机分为假手术组(n=6)和实验组(n=24),实验组大鼠采用5/6肾切除术(Platt法)+高磷(P)饮食[1.2%P,1.0%钙(Ca)]制备尿毒症高转化骨...目的:探讨血管紧张素(1-7)[Ang(1-7)]对大鼠尿毒症高转性骨病的影响,并阐明其可能的机制。方法:30只SD大鼠随机分为假手术组(n=6)和实验组(n=24),实验组大鼠采用5/6肾切除术(Platt法)+高磷(P)饮食[1.2%P,1.0%钙(Ca)]制备尿毒症高转化骨病模型,并将建模成功的大鼠随机分为模型组、Ang(1-7)组、血管紧张素转换酶2(ACE2)激活剂二乙酰胺三氮脒(DIZE)组(DIZE组)和Mas受体拮抗剂组(A779组),每组6只。分别于手术后12和18周采用全自动生化分析仪检测各组大鼠血清Ca、P、血肌酐(Scr)、血尿素氮(BUN)和24 h尿蛋白(UP)水平;免疫化学荧光法测定各组大鼠全段甲状旁腺素(iPTH)水平;酶联免疫吸附试验(ELISA)法检测各组大鼠血清骨钙素(OC)、Ⅰ型胶原N端肽(NTX)和抗酒石酸酸性磷酸酶(TRAP)-5b水平;高分辨率显微CT扫描检测各组大鼠股骨组织的骨密度(BMD)、组织骨密度(TMD)、骨小梁厚度(Tb.Th)和骨小梁分离度(Tb.Sp)等三维结构参数。Von Kossa染色和吉姆萨染色观察各组大鼠皮质骨及骨小梁病理形态表现,计算骨小梁体积(TBV);荧光显微镜下测定各组大鼠骨矿化率(MAR),并计算成骨细胞指数(OBI)和破骨细胞指数(OCI)。结果:术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠体质量减小(P<0.05);术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠血清中24 h UP、Scr及BUN水平均升高(P<0.05);术后18周,与模型组比较,Ang(1-7)组和DIZE组大鼠血清中24 h UP及Scr水平均降低(P<0.05),A779组大鼠血清中24 h UP、Scr和BUN水平均升高(P<0.05)。证实尿毒症高转化骨病大鼠模型构建成功。术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠血清中iPTH、P、OC、NTX及TRAP-5b水平均升高(P<0.05);术后18周,与模型组比较,Ang(1-7)组和DIZE组大鼠血清中NTX及TRAP-5b水平均降低(P<0.05),A779组大鼠血清中iPTH、P、NTX和TRAP-5b水平均升高(P<0.05)。高分辨率显微CT扫描检测,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠股骨BMD及TMD均降低(P<0.05);与模型组比较,Ang(1-7)组和DIZE组大鼠股骨BMD及TMD均升高(P<0.05),A779组大鼠股骨BMD和TMD均降低(P<0.05)。与假手术组比较,模型组大鼠股骨Tb.Th降低(P<0.05),Tb.Sp升高(P<0.05);Ang(1-7)组和DIZE组大鼠股骨Tb.Th升高(P<0.05),而Tb.Sp降低(P<0.05);与模型组比较,A779组大鼠股骨Tb.Th降低(P<0.05),而Tb.Sp升高(P<0.05)。骨病理检查,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠股骨TBV均降低(P<0.05),MAR、OBI和OCI均升高(P<0.05);与模型组比较,Ang(1-7)组和DIZE组大鼠股骨OBI及OCI均降低(P<0.05),TBV升高(P<0.05),而A779组大鼠股骨OBI和OCI均升高(P<0.05),TBV降低(P<0.05)。结论:ACE2/Ang(1-7)/Mas轴对尿毒症大鼠高转化骨病具有改善作用。展开更多
文摘Subjective: This study aimed to investigate the therapeutic mechanisms of 7-hydroxyflavone (7-HF) in treating myocardial ischemia/reperfusion injury (MI/RI) via network pharmacology, molecular docking, target validation, and experiments at the animal level. Methods: Firstly, the genes of 7-HF were acquired from PharmMapper, TCMSP, and SwissTargetPrediction. At the same time, MI/RI-related genes were obtained from OMIM, GeneCards, and TTD online platforms. Subsequently, string platform and Cytoscape 3.9.2 were used to construct protein-protein interaction network diagrams and 7-HF-targets-signaling pathways-MI/RI network. Then, the Metascape platform was used to conduct functional enrichment analyses. Next, AutoDock Vina and Pymol were used to perform molecular docking. The hub targets were validated in the GSE66360. Lastly, SOD, MDA, transmission electron microscope, quantitative real-time PCR, and western blot were used to validate in MI/RI rats. Results: 139 genes of 7-HF, 4832 genes of MI/RI were obtained. The 47 interact genes between 7-HF and MI/RI targets for MI/RI were likely to act through multiple pathways. And NQO1 was a critical target in the above process. In an animal experiment, 7-HF could relieve the injured interfibrillar mitochondria and myocardial fibers, decrease the expression of MDA and SOD, and increase the expression of Nrf2, NQO1 and HO-1 in the mRNA and protein level in the MI/RI rats. Conclusion: This study preliminarily demonstrated that 7-HF could provide cardioprotection by inhibiting the oxidative stress and up-regulating Nrf2/NQO1/HO-1 signaling pathway based on network pharmacology, molecular docking, target validation, and animal experiments.
文摘目的:探讨血管紧张素(1-7)[Ang(1-7)]对大鼠尿毒症高转性骨病的影响,并阐明其可能的机制。方法:30只SD大鼠随机分为假手术组(n=6)和实验组(n=24),实验组大鼠采用5/6肾切除术(Platt法)+高磷(P)饮食[1.2%P,1.0%钙(Ca)]制备尿毒症高转化骨病模型,并将建模成功的大鼠随机分为模型组、Ang(1-7)组、血管紧张素转换酶2(ACE2)激活剂二乙酰胺三氮脒(DIZE)组(DIZE组)和Mas受体拮抗剂组(A779组),每组6只。分别于手术后12和18周采用全自动生化分析仪检测各组大鼠血清Ca、P、血肌酐(Scr)、血尿素氮(BUN)和24 h尿蛋白(UP)水平;免疫化学荧光法测定各组大鼠全段甲状旁腺素(iPTH)水平;酶联免疫吸附试验(ELISA)法检测各组大鼠血清骨钙素(OC)、Ⅰ型胶原N端肽(NTX)和抗酒石酸酸性磷酸酶(TRAP)-5b水平;高分辨率显微CT扫描检测各组大鼠股骨组织的骨密度(BMD)、组织骨密度(TMD)、骨小梁厚度(Tb.Th)和骨小梁分离度(Tb.Sp)等三维结构参数。Von Kossa染色和吉姆萨染色观察各组大鼠皮质骨及骨小梁病理形态表现,计算骨小梁体积(TBV);荧光显微镜下测定各组大鼠骨矿化率(MAR),并计算成骨细胞指数(OBI)和破骨细胞指数(OCI)。结果:术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠体质量减小(P<0.05);术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠血清中24 h UP、Scr及BUN水平均升高(P<0.05);术后18周,与模型组比较,Ang(1-7)组和DIZE组大鼠血清中24 h UP及Scr水平均降低(P<0.05),A779组大鼠血清中24 h UP、Scr和BUN水平均升高(P<0.05)。证实尿毒症高转化骨病大鼠模型构建成功。术后12和18周,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠血清中iPTH、P、OC、NTX及TRAP-5b水平均升高(P<0.05);术后18周,与模型组比较,Ang(1-7)组和DIZE组大鼠血清中NTX及TRAP-5b水平均降低(P<0.05),A779组大鼠血清中iPTH、P、NTX和TRAP-5b水平均升高(P<0.05)。高分辨率显微CT扫描检测,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠股骨BMD及TMD均降低(P<0.05);与模型组比较,Ang(1-7)组和DIZE组大鼠股骨BMD及TMD均升高(P<0.05),A779组大鼠股骨BMD和TMD均降低(P<0.05)。与假手术组比较,模型组大鼠股骨Tb.Th降低(P<0.05),Tb.Sp升高(P<0.05);Ang(1-7)组和DIZE组大鼠股骨Tb.Th升高(P<0.05),而Tb.Sp降低(P<0.05);与模型组比较,A779组大鼠股骨Tb.Th降低(P<0.05),而Tb.Sp升高(P<0.05)。骨病理检查,与假手术组比较,模型组、Ang(1-7)组、DIZE组和A779组大鼠股骨TBV均降低(P<0.05),MAR、OBI和OCI均升高(P<0.05);与模型组比较,Ang(1-7)组和DIZE组大鼠股骨OBI及OCI均降低(P<0.05),TBV升高(P<0.05),而A779组大鼠股骨OBI和OCI均升高(P<0.05),TBV降低(P<0.05)。结论:ACE2/Ang(1-7)/Mas轴对尿毒症大鼠高转化骨病具有改善作用。
